Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Zydus randomises 'first patient' in phase 2 trial of Saroglitazar Mg in NASH

Ruchika Sharma23 Oct 2021 12:47 PM IST

Ahmedabad: Zydus, a global pharmaceutical company has recently announced that the company has randomised the first patient into the Phase 2(b)...

With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more entrenched

Ruchika Sharma22 Oct 2021 3:03 PM IST

New Delhi: As the country achieved the milestone of vaccinating over 100 crore Indians against COVID-19 on Thursday, India's role as the pharmacy of...

COVID booster shot showed high efficacy in large study: Pfizer, BioNTech

Ruchika Sharma22 Oct 2021 3:01 PM IST

New York: Pfizer Inc. and BioNTech SE have recently announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and...

Novartis intrathecal onasemnogene abeparvovec Phase III study

Novartis, BioNTech ink pact to support fill, finish of mRNA Pfizer-BioNTech COVID vaccine

Ruchika Sharma22 Oct 2021 2:54 PM IST

Basel: Novartis has announced that the company has signed an initial agreement to leverage its manufacturing capacity and capabilities to address the...

Serum Institute sees 'large' Covid-19 vaccine exports as output nearly quadruples

Ruchika Sharma22 Oct 2021 12:46 PM IST

New Delhi: The Serum Institute of India (SII), the world's biggest vaccine maker, has nearly quadrupled its monthly capacity of AstraZeneca shots...

Biocon Biologics, Viatris interchangeable biosimilar Insulin Glargine preferred on Express Scripts' largest formulary in US

Ruchika Sharma21 Oct 2021 3:28 PM IST

Bengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd. has recently announced that Express Scripts, a pharmacy benefit management...

Abbott raises annual earnings outlook as COVID test sales rebound

Ruchika Sharma21 Oct 2021 3:06 PM IST

New Delhi: Abbott Laboratories said demand for its COVID-19 tests, especially rapid testing, rebounded as the U.S. wrestled with surging coronavirus...

WHO seeks additional information on Covaxin from Bharat Biotech

Ruchika Sharma21 Oct 2021 1:03 PM IST

United Nations/Geneva: The World Health Organisation on Monday said it was expecting additional information from India's Bharat Biotech regarding its...

USFDA clears Moderna, JnJ boosters, allows mixing Covid vaccines

Ruchika Sharma21 Oct 2021 1:01 PM IST

New Delhi: The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson &...

Novavax tumbles after report on COVID vaccine production delay

Ruchika Sharma21 Oct 2021 10:00 AM IST

New Delhi: Shares of Novavax Inc fell 16% after a report from Politico said the company faces significant hurdles in proving it can manufacture its...

AstraZeneca launches clinical data, insights division in India

Ruchika Sharma20 Oct 2021 5:02 PM IST

New Delhi: AstraZeneca India Private Limited, the Global Capability Centre (GCC) of AstraZeneca has launched a clinical data and insights division in...

Gilead Biktarvy expanded indication for HIV-1 treatment in pediatrics gets USFDA okay

Ruchika Sharma20 Oct 2021 2:32 PM IST

Foster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (USFDA) has approved a new low-dose tablet dosage form of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok